Wier PJ - Search Results

1

Preclinical safety of recombinant human interleukin-18.

Herzyk DJ, Bugelski PJ, Hart TK, Wier PJ. Herzyk DJ, et al. Among authors: wier pj. Toxicol Pathol. 2003 Sep-Oct;31(5):554-61. doi: 10.1080/01926230390226681. Toxicol Pathol. 2003. PMID: 14692624

2

Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.

Bugelski PJ, Herzyk DJ, Rehm S, Harmsen AG, Gore EV, Williams DM, Maleeff BE, Badger AM, Truneh A, O'Brien SR, Macia RA, Wier PJ, Morgan DG, Hart TK. Bugelski PJ, et al. Among authors: wier pj. Hum Exp Toxicol. 2000 Apr;19(4):230-43. doi: 10.1191/096032700678815783. Hum Exp Toxicol. 2000. PMID: 10918514

3

Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero.

Herzyk DJ, Bugelski PJ, Hart TK, Wier PJ. Herzyk DJ, et al. Among authors: wier pj. Hum Exp Toxicol. 2002 Sep-Oct;21(9-10):507-12. doi: 10.1191/0960327102ht289oa. Hum Exp Toxicol. 2002. PMID: 12458908

4

Spontaneous and induced alterations in the cardiac membranous ventricular septum of fetal, weanling, and adult rats.

Solomon HM, Wier PJ, Fish CJ, Hart TK, Johnson CM, Posobiec LM, Gowan CC, Maleeff BE, Kerns WD. Solomon HM, et al. Among authors: wier pj. Teratology. 1997 Mar;55(3):185-94. doi: 10.1002/(SICI)1096-9926(199703)55:3<185::AID-TERA3>3.0.CO;2-1. Teratology. 1997. PMID: 9181672

5

Effects of food restriction on testis and accessory sex glands in maturing rats.

Rehm S, White TE, Zahalka EA, Stanislaus DJ, Boyce RW, Wier PJ. Rehm S, et al. Among authors: wier pj. Toxicol Pathol. 2008 Jul;36(5):687-94. doi: 10.1177/0192623308320275. Epub 2008 Jul 22. Toxicol Pathol. 2008. PMID: 18648097

6

Artesunate: developmental toxicity and toxicokinetics in monkeys.

Clark RL, Arima A, Makori N, Nakata Y, Bernard F, Gristwood W, Harrell A, White TE, Wier PJ. Clark RL, et al. Among authors: wier pj. Birth Defects Res B Dev Reprod Toxicol. 2008 Aug;83(4):418-34. doi: 10.1002/bdrb.20163. Birth Defects Res B Dev Reprod Toxicol. 2008. PMID: 18702116

7

Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits.

Treinen KA, Louden C, Dennis MJ, Wier PJ. Treinen KA, et al. Among authors: wier pj. Teratology. 1999 Jan;59(1):51-9. doi: 10.1002/(SICI)1096-9926(199901)59:1<51::AID-TERA10>3.0.CO;2-I. Teratology. 1999. PMID: 9988883

8

Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene.

Rehm S, Solleveld HA, Portelli ST, Wier PJ. Rehm S, et al. Among authors: wier pj. Birth Defects Res B Dev Reprod Toxicol. 2007 Jun;80(3):225-32. doi: 10.1002/bdrb.20119. Birth Defects Res B Dev Reprod Toxicol. 2007. PMID: 17570126

9

Identification of drug-induced hyper- or hypoprolactinemia in the female rat based on general and reproductive toxicity study parameters.

Rehm S, Stanislaus DJ, Wier PJ. Rehm S, et al. Among authors: wier pj. Birth Defects Res B Dev Reprod Toxicol. 2007 Jun;80(3):253-7. doi: 10.1002/bdrb.20126. Birth Defects Res B Dev Reprod Toxicol. 2007. PMID: 17570137

10

An evaluation of the novel selective estrogen receptor modulator, idoxifene, for effects on reproduction in rats and rabbits.

Treinen KA, Rehm S, Wier PJ. Treinen KA, et al. Among authors: wier pj. Toxicol Sci. 1998 Feb;41(2):199-207. doi: 10.1006/toxs.1997.2404. Toxicol Sci. 1998. PMID: 9520356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page